Kevin Tan
CIK 1884056 · CFO & Treasurer · last filed 2026-04-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$748.5K
Companies
2
Total Filings
15
Lifetime Open-Market Net
-$375.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SLDB | CFO & Treasurer | 104,826 | $7.14 | $748.5K | -$390.2K | 12 | 2026-04-21 |
| Cartesian Therapeutics, Inc. (SELB) Delisted | Chief Financial Officer | 77,000 | $0.88 | $67.9K | $15.1K | 3 | 2022-01-05 |
Recent Filings · Page 2 of 2
15 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-01-11 | SLDB | Mixed | +7,315 | -$32.3K | EDGAR |
| 2023-01-11 | SLDB | Grant (A) | — | $0 | EDGAR |
| 2022-01-05 | Cartesian Therapeutics, Inc. (SELB) Delisted | Grant (A) | +72,000 | $0 | EDGAR |
| 2021-12-06 | Cartesian Therapeutics, Inc. (SELB) Delisted | Buy (P) | +5,000 | $15.1K | EDGAR |
| 2021-09-22 | Cartesian Therapeutics, Inc. (SELB) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–15 of 15
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.